Rate 1 (SAC): The percentage of patients aged 5-50 years as of the last day of the measurement year with persistent asthma who were dispensed more than 3 canisters of a short-acting beta2 agonist inhaler during the same 90-day period.
Rate 2 (ACT): The percentage of patients aged 5-50 years as of the last day of the measurement year with persistent asthma who were dispensed more than 3 canisters of short-acting beta2 agonist inhalers over a 90-day period and who did not receive controller therapy during the same 90-day period.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.20 Testing Data Sources
-
1.14 Numerator
Rate 1 (SAC): Patients in the denominator who received more than 3 canisters of short-acting Beta2 Agonist Inhalers within a 90-day period. From the date of each prescription fill, count the total number of canisters of short-acting Beta2 Agonist Inhalers dispensed at that fill and dispensed within 90 days of that fill. If the patient receives more than 3 canisters in at least one 90-day period, then the patient is included in the numerator. (Note: This is a count of canisters dispensed, not prescriptions filled. If a patient received 2 canisters at one fill, it counts as 2 canisters.)
Rate 2 (ACT): Patients in the denominator who were not dispensed a controller therapy medication during the same 90-day period where they received more than 3 canisters of short-acting Beta2 Agonist inhalers.
-
1.15 Denominator
Rate 1 (SAC): Patients aged 5-50 years as of the last day of the measurement year who were dispensed consecutive fills (consecutive fills = the dispensing of two asthma medications on different days within 120 days of one another) for asthma medication during the measurement year, excluding those patients who were dispensed one or more prescriptions for a COPD medication, or one or more prescriptions for a cystic fibrosis medication, or one or more prescriptions for a nasal steroid medication during the measurement year.
Rate 2 (ACT): Patients aged 5-50 years as of the last day of the measurement year who were dispensed consecutive fills (consecutive fills = the dispensing of two asthma medications on different days within 120 days of one another) for asthma medication during the measurement year, excluding those patients who were dispensed one or more prescriptions for a COPD medication, or one or more prescriptions for a cystic fibrosis medication, or one or more prescriptions for a nasal steroid medication during the measurement year.
-
Exclusions
For rates 1 & 2, exclude any patient who filled:
• One or more prescriptions for a COPD medication during the measurement year; or
• One or more prescriptions for a cystic fibrosis medication during the measurement year; or
• One or more prescriptions for a nasal steroid medication during the measurement year.
-
1.13a Data dictionary not attachedNo
-
Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Pulmonary and Critical Care Project 2015-2016Initial EndorsementLast UpdatedRemoval Date
-
StewardSteward Organization EmailSteward Organization URLSteward Organization Copyright
NA
-
-
-
Risk AdjustmentRisk adjustment approachOffRisk adjustment approachOffConceptual model for risk adjustmentOffConceptual model for risk adjustmentOff
-